Lv63
2870 积分 2023-08-18 加入
Impact of single versus multiple surgeries in CRSwNP patients undergoing treatment with dupilumab
1个月前
已完结
The extra cost of biologics as first-line treatment in uncontrolled chronic rhinosinusitis with nasal polyps with no previous sinus surgery is overwhelming: a budget impact analysis
1个月前
已完结
One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study
1个月前
已完结
Improving sleep in severe CRSwNP: an RCT on the effect of mepolizumab and FESS on OSA, sleep disturbances and quality of life
1个月前
已完结
endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies
1个月前
已完结
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab
3个月前
已完结
Biologics and Surgery in Chronic Rhinosinusitis With Nasal Polyps: A Comparative Outcomes Analysis
3个月前
已完结
Multi-institutional minimal clinically important difference of the 22-item Sinonasal Outcome Test in medically managed chronic rhinosinusitis
4个月前
已完结
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps
5个月前
已完结
皖公网安备34019202002308
